Skip to main content
GENEDRIVE PLC logo

GENEDRIVE PLC — Investor Relations & Filings

Ticker · GDR ISIN · GB00B1VKB244 LEI · 213800ZYODIRZ87Y4K14 IL Manufacturing
Open in API
Filings indexed 606 across all filing types
Latest filing 2023-04-11 Major Shareholding Noti…
Country GB United Kingdom
Listing IL GDR

About GENEDRIVE PLC

https://genedriveplc.com/

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains fields detailing the acquisition or disposal of voting rights, the identity of the shareholder (RiverFort Global Opportunities PCC Ltd), the date the threshold was crossed (6th April 2023), and the resulting percentage of voting rights (6.56%). This structure is characteristic of regulatory filings related to significant changes in share ownership. The presence of 'RNS Number' and the footer referencing the London Stock Exchange and the Financial Conduct Authority confirms it is a regulatory disclosure. Since the classification list includes 'Major Shareholding Notification' (MRQ) for changes in significant share ownership levels crossing thresholds, this is the most appropriate specific category. It is not a general regulatory filing (RNS) because a more specific category exists.
2023-04-11 English
Total Voting Rights
Regulatory Filings Classification · 1% confidence The document is explicitly labeled with an 'RNS Number' and contains language typical of regulatory news service announcements, such as referencing the 'UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1' and providing the 'Total Voting Rights'. This type of filing, which announces a specific regulatory metric (total voting rights) based on recent share issuance, fits best under the general category for regulatory announcements that are not one of the highly specific types like 10-K, ER, or DIV. Since it is a formal regulatory notification provided via RNS, and it doesn't fit perfectly into the other specific categories (like DIRS, SHA, or DVA, although it relates to share capital), the most appropriate classification is the general Regulatory Filings category (RNS). The document length (3611 chars) is short, but it is a primary announcement, not just an announcement *of* another report, so RPA is less suitable than RNS for this specific regulatory update.
2023-04-06 English
£5 million Equity Prepayment Facility
Regulatory Filings Classification · 1% confidence The document is an official announcement from Genedrive PLC, identified by the 'RNS Number' and the header indicating it is 'deemed... to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014'. The core content details the agreement of an 'Equity Prepayment Facility for up to £5 million' and an initial draw down. This is a financing activity. While it mentions 'interim results' were issued today, the primary purpose of this specific filing is the announcement of the new financing agreement, which falls under Capital/Financing Update (CAP). It is not the Interim Report itself (IR) or the Earnings Release (ER), but a specific corporate action related to funding.
2023-03-31 English
Half-year Report
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim results to 31 December 2022' for Genedrive PLC. It contains comprehensive financial statements, including the Consolidated Statement of Comprehensive Income and the Consolidated Statement of Changes in Equity for the six-month period. It also includes an Interim Management Report, operating highlights, and financial analysis. Since it provides substantive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report (IR). H1 2023
2023-03-31 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document explicitly starts with 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange' multiple times. It details a 'Price Monitoring Extension' and includes a service notice about RNS ceasing publication of PME notices. This content is a general regulatory announcement disseminated through the RNS system, which aligns best with the 'Regulatory Filings' category, especially since it doesn't fit the specific definitions for financial reports (10-K, IR, ER) or corporate actions (DIV, SHA, CAP). The document length is short (1891 chars), suggesting it is a brief announcement rather than a comprehensive report.
2023-03-30 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1932 characters) and contains the header 'RNS Number : 7650U'. It announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. The text explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This indicates it is a general regulatory announcement disseminated via the RNS system, rather than a specific financial report like an ER, 10-K, or IR. Since it is a general regulatory notice that doesn't fit the other specific categories (like DIRS, DIV, or CAP), the most appropriate classification is the general regulatory fallback category.
2023-03-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.